Published in Cytometry on June 01, 2000
The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells. J Biomed Biotechnol (2007) 0.87
In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat Biotechnol (2001) 8.88
The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities. Proc Natl Acad Sci U S A (2000) 7.70
Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl Environ Microbiol (1994) 6.26
Metabolic modeling of microbial strains in silico. Trends Biochem Sci (2001) 4.29
Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective. J Theor Biol (2000) 4.23
Transient confinement of a glycosylphosphatidylinositol-anchored protein in the plasma membrane. Biochemistry (1997) 3.59
Robustness analysis of the Escherichia coli metabolic network. Biotechnol Prog (2000) 3.40
Systems properties of the Haemophilus influenzae Rd metabolic genotype. J Biol Chem (1999) 2.92
Protein lateral mobility as a reflection of membrane microstructure. Bioessays (1993) 2.91
Metabolic pathway analysis: basic concepts and scientific applications in the post-genomic era. Biotechnol Prog (1999) 2.66
Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol (1997) 2.64
Stoichiometric interpretation of Escherichia coli glucose catabolism under various oxygenation rates. Appl Environ Microbiol (1993) 2.62
Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions. BMC Bioinformatics (2000) 2.50
Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis. J Theor Biol (2000) 2.49
Metabolic capabilities of Escherichia coli: I. synthesis of biosynthetic precursors and cofactors. J Theor Biol (1993) 2.39
Network analysis of intermediary metabolism using linear optimization. I. Development of mathematical formalism. J Theor Biol (1992) 2.21
Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ (2011) 2.21
Characterization of metabolism in the Fe(III)-reducing organism Geobacter sulfurreducens by constraint-based modeling. Appl Environ Microbiol (2006) 2.09
Older people's views of advice about falls prevention: a qualitative study. Health Educ Res (2006) 2.08
Pseudolinkage of the duplicate loci for supernatant aspartate aminotransferase in brook trout, Salvelinus fontinalis. J Hered (1980) 1.97
Toward metabolic phenomics: analysis of genomic data using flux balances. Biotechnol Prog (1999) 1.93
Repression of yeast Ste12 transcription factor by direct binding of unphosphorylated Kss1 MAPK and its regulation by the Ste7 MEK. Genes Dev (1998) 1.92
Dynamic simulation of the human red blood cell metabolic network. Bioinformatics (2001) 1.92
Alterations in the Young's modulus and volumetric properties of chondrocytes isolated from normal and osteoarthritic human cartilage. J Biomech (1999) 1.91
Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol (1996) 1.85
Biomass as a source of chemical feedstocks: an economic evaluation. Science (1981) 1.78
The underlying pathway structure of biochemical reaction networks. Proc Natl Acad Sci U S A (1998) 1.78
Metabolic dynamics in the human red cell. Part III--Metabolic reaction rates. J Theor Biol (1990) 1.63
Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. J Virol (1996) 1.61
Flux-balance analysis of mitochondrial energy metabolism: consequences of systemic stoichiometric constraints. Am J Physiol Regul Integr Comp Physiol (2001) 1.59
Metabolic dynamics in the human red cell. Part I--A comprehensive kinetic model. J Theor Biol (1989) 1.58
Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion. Proc Natl Acad Sci U S A (1997) 1.55
Biochemical production capabilities of Escherichia coli. Biotechnol Bioeng (1993) 1.54
Viscoelastic properties of chondrocytes from normal and osteoarthritic human cartilage. J Orthop Res (2000) 1.51
Network analysis of intermediary metabolism using linear optimization. II. Interpretation of hybridoma cell metabolism. J Theor Biol (1992) 1.49
Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. Hum Gene Ther (1996) 1.43
The deformation behavior and mechanical properties of chondrocytes in articular cartilage. Osteoarthritis Cartilage (1999) 1.42
Effect of medium osmolarity on hybridoma growth, metabolism, and antibody production. Biotechnol Bioeng (1991) 1.41
Two new pseudopod morphologies displayed by the human hematopoietic KG1a progenitor cell line and by primary human CD34(+) cells. Blood (1998) 1.40
Reducing complexity in metabolic networks: making metabolic meshes manageable. Fed Proc (1987) 1.31
How will bioinformatics influence metabolic engineering? Biotechnol Bioeng (1999) 1.30
Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood (1999) 1.29
Retroviral infection is limited by Brownian motion. Hum Gene Ther (1996) 1.29
Measures of clinical agreement for nominal and categorical data: the kappa coefficient. Comput Biol Med (1992) 1.24
Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur J Immunol (1995) 1.24
Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor. Biotechnol Prog (1992) 1.24
Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production. Biotechnol Bioeng (1992) 1.23
Mechanically cut mitotic spindles: clean cuts and stable microtubules. J Cell Sci (1989) 1.22
Properties of metabolic networks: structure versus function. Biophys J (2004) 1.22
Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine (2011) 1.22
Parametric sensitivity of stoichiometric flux balance models applied to wild-type Escherichia coli metabolism. Biotechnol Bioeng (1995) 1.20
ATP release by mechanically loaded porcine chondrons in pellet culture. Arthritis Rheum (2000) 1.20
Using the reconstructed genome-scale human metabolic network to study physiology and pathology. J Intern Med (2012) 1.20
Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood (1993) 1.18
Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J Virol (1997) 1.17
Genetic epidemiology. Annu Rev Public Health (1984) 1.17
Genetic analysis of cystic fibrosis: linkage of DNA and classical markers in multiplex families. Am J Hum Genet (1986) 1.15
Cell-cycle-specific F plasmid replication: regulation by cell size control of initiation. J Bacteriol (1991) 1.14
Chemical decomposition of glutamine in cell culture media: effect of media type, pH, and serum concentration. Biotechnol Prog (1990) 1.13
Metabolic dynamics in the human red cell. Part IV--Data prediction and some model computations. J Theor Biol (1990) 1.12
Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol Bioeng (1998) 1.11
Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells. Appl Microbiol Biotechnol (2003) 1.11
Targeted adenovirus-mediated gene delivery to T cells via CD3. J Virol (1997) 1.09
A comprehensive model of human erythrocyte metabolism: extensions to include pH effects. Biomed Biochim Acta (1990) 1.06
Mathematical modelling of dynamics and control in metabolic networks. I. On Michaelis-Menten kinetics. J Theor Biol (1984) 1.06
Laparoscopic colon surgery: unreliability of end-tidal CO2 monitoring. Acta Anaesthesiol Scand (2008) 1.05
Involvement of Alu sequences in the cell-specific regulation of transcription of the gamma chain of Fc and T cell receptors. J Biol Chem (1993) 1.04
Picogram per cell determination of DNA by flow cytofluorometry. Anal Biochem (1984) 1.04
Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation. Thromb Haemost (2013) 1.03
Optimal selection of metabolic fluxes for in vivo measurement. II. Application to Escherichia coli and hybridoma cell metabolism. J Theor Biol (1992) 1.03
Elemental balancing of biomass and medium composition enhances growth capacity in high-density Chlorella vulgaris cultures. Biotechnol Bioeng (1998) 1.01
Anaerobic and aerobic degradation of pyridine by a newly isolated denitrifying bacterium. Appl Environ Microbiol (1997) 1.01
Optimal selection of metabolic fluxes for in vivo measurement. I. Development of mathematical methods. J Theor Biol (1992) 1.00
Metabolic dynamics in the human red cell. Part II--Interactions with the environment. J Theor Biol (1989) 0.99
Epidemiology of acute viral respiratory tract infections in Korean children. J Infect (2000) 0.99
Detection of Chlamydia trachomatis cervical infection by urine tests among adolescents clinics. J Adolesc Health (1998) 0.99
Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J Virol (1997) 0.98
Effects of dissolved oxygen on hybridoma cell growth, metabolism, and antibody production kinetics in continuous culture. Biotechnol Prog (1991) 0.98
An evaluation of five protocols for surgical handwashing in relation to skin condition and microbial counts. J Hosp Infect (1997) 0.97
Increased neurite outgrowth induced by inhibition of protein tyrosine kinase activity in PC12 pheochromocytoma cells. J Neurochem (1993) 0.97
Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure. Biotechnol Bioeng (1998) 0.94
Proctolin in the lobster: the distribution, release, and chemical characterization of a likely neurohormone. J Neurosci (1984) 0.94
Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1-->6) dextran antibody. J Immunol (1999) 0.92
ATP induces Ca(2+) signaling in human chondrons cultured in three-dimensional agarose films. Osteoarthritis Cartilage (2001) 0.91
High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology (Berl) (1995) 0.90
Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 1. Analysis of data from controlled batch reactors. Biotechnol Prog (1992) 0.90
Determination of specific oxygen uptake rates in human hematopoietic cultures and implications for bioreactor design. Ann Biomed Eng (1996) 0.90
Kinetics of retroviral production from the amphotropic ΨCRIP murine producer cell line. Cytotechnology (1996) 0.89
Kinetics of retrovirus mediated gene transfer: the importance of intracellular half-life of retroviruses. J Theor Biol (1996) 0.89
Novel role of KCNQ2/3 channels in regulating neuronal cell viability. Cell Death Differ (2010) 0.89
Predictions for oxygen supply control to enhance population stability of engineered production strains. Biotechnol Bioeng (1994) 0.89
Overexpression of bcl-2 inhibits sodium butyrate-induced apoptosis in Chinese hamster ovary cells resulting in enhanced humanized antibody production. Biotechnol Bioeng (2001) 0.89
Influence of a supplementary carbon source on biodegradation of pyridine by freely suspended and immobilized Pimelobacter sp.. Appl Microbiol Biotechnol (1996) 0.88
Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Biotechnology (N Y) (1993) 0.88
Production of monoclonal antibody using free-suspended and immobilized hybridoma cells: Effect of serum. Biotechnol Bioeng (1991) 0.88
Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J Neurooncol (2005) 0.88
Review: tissue engineering: reconstitution of human hematopoiesis ex vivo. Biotechnol Bioeng (1993) 0.88
Quantitative analysis of Escherichia coli metabolic phenotypes within the context of phenotypic phase planes. J Mol Microbiol Biotechnol (2003) 0.88
The standardization of Achenbach's Youth Self-Report in Greece in a national sample of high school students. Eur Child Adolesc Psychiatry (2001) 0.87